BESIMPTA
DEAD

Serial Number

88746136

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jan 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BESIMPTA Trademark

Serial Number: 88746136

BESIMPTA is a trademark filed by NOVARTIS AG on January 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 3, 2020

Registration Date

Not Registered

Published for Opposition

March 10, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 12, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 12, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 4, 2022 EXRA
SOU EXTENSION 4 GRANTED
May 2, 2022 EX4G
SOU EXTENSION 4 FILED
May 2, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
May 2, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 3, 2021 EXRA
SOU EXTENSION 3 GRANTED
Nov 1, 2021 EX3G
SOU EXTENSION 3 FILED
Nov 1, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 1, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 5, 2021 EXRA
SOU EXTENSION 2 GRANTED
May 3, 2021 EX2G
SOU EXTENSION 2 FILED
May 3, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
May 3, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 3, 2020 EXRA
SOU EXTENSION 1 GRANTED
Oct 30, 2020 EX1G
SOU EXTENSION 1 FILED
Oct 30, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 30, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2020 CNSA
ASSIGNED TO EXAMINER
Feb 4, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2020 NWOS
NEW APPLICATION ENTERED
Jan 7, 2020 NWAP